Trial Profile
The effects of statin therapy on the osteoprotegerin-RANKL system, correlation with vascular disease and bone metabolism in patients with Type 2 diabetes.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis; Diabetic angiopathies
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 18 Aug 2011 New trial record